23rd Annual Intensive Update with Board Review in Geriatric and Palliative Medicine

Tuesday, September 24, 2024, 8:00 AM - Friday, September 27, 2024, 5:00 AM, Online, New york , NY


The Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai is the nation’s largest training program in the field and has trained one out of five geriatricians nationwide. We are offering the 23rd annual “Intensive Update with Board Review in Geriatric and Palliative Medicine”. This is a four-day clinically-based intensive course in geriatrics and palliative medicine taught by leading experts in both fields providing updates on geriatric syndromes and palliative medicine and the latest research and treatments. Each day consists of eight live virtual plenary group sessions and 20 pre-recorded workshops designated to provide both practical experience with the large group material, as well as to cover other content areas. All workshops are case-based and can be viewed at the learner’s time discretion. Four Comprehensive Board Review Q&A sessions take place during Tuesday-Friday. This course is sponsored by the Mount Sinai School of Medicine, Brookdale Department of Geriatrics & Palliative Medicine.

1. Describe the latest evidence-basedgeriatric and palliative medicine.
2. Describe strategies for clinical decision-making and deprescribing in the setting of multiple conditions.
3. Discuss the framework of the 5Ms as an approach to care for older adults.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (48.00 hours), ABIM MOC Part 2 (48.00 hours), Non-Physician Attendance (48.00 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Icahn School of Medicine at Mount Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.